Abstract
Several challenges need to be overcome when applying nucleic acids as therapeutic agents. We developed a new way to control the onset of the release of cholesterol-conjugated oligonucleotides with a simple, versatile, and cheap platform. Moreover, we combine the platform into a dual-release system that can release a hydrophobic drug with zero-order kinetics, followed by a rapid release of cholesterol-conjugated DNA.
Original language | English |
---|---|
Pages (from-to) | 8099-8102 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 59 |
Issue number | 52 |
DOIs | |
State | Published - 23 May 2023 |